Patent Grant
10646321
This application claims benefit of and priority to European Patent Application Serial No. 16305063.6 filed Jan. 25, 2016, the disclosure of the above-identified application is hereby incorporated by reference in its entirety.
The present invention relates to a prosthesis, for example a prosthesis for treating hernias of the abdominal wall, comprising a reinforcement layer capable of promoting tissue ingrowth, and two barrier layers capable of preventing post-surgical adhesions on the prosthesis and on the fixing means provided for fixing the prosthesis on the abdominal wall.
The abdominal wall in humans is composed of fat and muscles interconnected by fascias. The abdominal wall forms the anterior enclosure of the abdominal cavity in which are lodged the viscera organs such as the intestines, the stomach, etc. . . . said viscera organs being enclosed in the peritoneum. It sometimes happens that a break in continuity occurs in the fascias, allowing part of the peritoneum to slip through and form a sac, or a hernia, containing either fat or part of the intestines, said sac protruding into the abdominal wall, thereby creating a defect in said wall and weakening it. Hernias or incisional hernias (a hernia occurring through a parietal surgical scar) show themselves in the form of a bulge at the surface of the skin and are classed, for example, as umbilical or ventral hernias or incisional hernias, depending on where they are located.
In order to repair a hernia defect, surgeons usually use a prosthesis comprising a reinforcement layer of tissue ingrowth material, said reinforcement layer replacing and/or strengthening the weakened anatomical tissues. The efficiency of the prosthesis, hence the ability to minimize the risks of recurrence, depends to a large extent on how well the prosthesis is fixed to the surrounding biological tissues.
The prosthesis may be fixated over, under or within the defect. When the prosthesis is fixed under the defect, it must be introduced in the abdominal cavity in the first place and then anchored to the abdominal wall.
One method of hernia repair involves open surgery, with incision of the skin and then of the abdominal wall. In such a surgery, the prosthesis is introduced in the implantation site via the incision made in the skin. However, in this type of surgery, the surgeon has little space to work in and poor visibility.
Document U.S. Pat. No. 7, 824, 420 describes prosthesis intended to be used for hernia repair in an open surgery procedure. The prosthesis described in this document comprises two layers of tissue ingrowth material, namely material permitting tissue adhesion, joined together at their periphery, one of the two layers being provided with a central opening. The prosthesis therefore forms a sort of pocket accessible via said central opening. The prosthesis is introduced in the implantation site via the incision of the skin and the hernia defect. The recessed layer is positioned facing the abdominal wall with its central opening facing the hernia defect, while the other layer is positioned facing the abdominal cavity. The fixing means and fixing tools are introduced into the pocket formed by the prosthesis via the incision of the skin, the hernia defect and the central opening of the prosthesis. The surgeon then fixes the prosthesis to the abdominal wall by attaching the tissue ingrowth material of the recessed layer to the abdominal wall. To do this, the surgeon fires fixing means through the tissue ingrowth material of the recessed layer and into the abdominal wall from the pocket formed by the prosthesis.
Another method of hernia repair involves laparoscopic surgery, wherein the prosthesis is conveyed in the abdominal cavity thanks to a trocar into which it is placed. The advantages of laparoscopic hernia repair include reduced pain and hospital stay, rapid convalescence, quicker return to work, better functional and cosmetic results. In laparoscopic surgery, the abdominal cavity is insufflated in order to create adequate space therein for the surgeon to handle, position and anchor the prosthesis to the abdominal wall with the help of tools introduced in the abdominal cavity via additional trocars. Such a surgery is known as the intraperitoneal route as the prosthesis is positioned on the abdominal wall from the “inside” of the peritoneum, namely from the inside of the abdominal cavity.
In such procedures, one face of the prosthesis bears on the abdominal wall while the opposite face of the prosthesis faces the viscera organs which are present in the abdominal cavity. It may then happen that following the surgical operation, some of the viscera organs adhere via a fibrin bridging mechanism to some parts of the prosthesis that face the abdominal cavity, such as for example the tissue ingrowth material forming the prosthesis and/or some of the fixing means used for fixing the prosthesis to the abdominal wall. Such a phenomenon may lead to risks for the patient such as transit dysfunction, occlusion or necrosis. In order to avoid these potential post-operative adhesions, a barrier layer is usually provided on the face of the prosthesis that is intended to face the abdominal cavity.
Anyway, it has been observed that the intraperitoneal repair of hernia defect could still lead to postoperative complications and early recurrences, in particular because of the exposure of the viscera organs to the parts of the prosthesis that face the abdominal cavity.
There is therefore the need for a prosthesis for the treatment of hernia, that would limit the potential postoperative complications due to the proximity between the prosthesis fixed to the abdominal wall and the viscera organs present in the abdominal cavity.
The present invention aims at providing a prosthesis for the treatment of hernia, in particular via the laparoscopic route, said prosthesis having a specific structure allowing it to minimize the risks of attachment of the viscera organs to the prosthesis posterior to the implantation of the prosthesis and to its fixation to the abdominal wall.
A first aspect of the invention is a prosthesis for treating a hernia defect in the abdominal wall comprising :
At least one reinforcement layer, comprising a biocompatible porous material, said reinforcement layer including a first surface intended to face the abdominal wall and a second surface opposite said first surface, said reinforcement layer being delimited by an outer edge,
At least one first barrier layer, comprising a biocompatible anti-adhesion material, said first barrier layer including a first surface and a second surface opposite said first surface of the first barrier layer, the first surface of the first barrier layer covering substantially at least a central part of the area of the second surface of said reinforcement layer, the second surface of said first barrier layer being intended to face the abdominal cavity, said first barrier layer being delimited by a peripheral outer edge,
At least one second barrier layer, said second barrier layer being shaped and dimensioned so as to cover at least the part of the area of the second surface of said reinforcement layer that is not covered by the first barrier layer, said second barrier layer being formed of one or more flap members, each flap member being formed of a piece of sheet of biocompatible anti-adhesion material and having at least an outer edge attached to the second surface of the reinforcement layer, and a free inner edge.
Within the meaning of the present application, “porous material” is understood as a material having pores, voids or holes, that are open and are distributed uniformly or irregularly and promote cell colonization and tissue ingrowth. The pores can be present in all types of configurations, for example as spheres, channels, hexagonal forms.
Within the meaning of the present application, “anti-adhesion material” is to be understood as meaning a biocompatible material that exhibits a continuous and smooth surface, for example non-porous, that minimizes tissue attachment by preventing providing space for cell recolonization, at least for the time period corresponding to the time during which post-surgical adhesions are likely to occur.
In the present application, the terms “outer” and “inner” are to be understood with respect to the prosthesis itself. For example, whatever the shape of the prosthesis, “inner” means in the direction of the centre of the prosthesis while “outer” refers to the direction towards the periphery and exterior of the prosthesis.
The prosthesis of the invention allows forming one or more protected spaces for positioning the fixing means intended to attach the prosthesis to the abdominal wall in a way allowing that said fixing means are prevented from entering in contact with the viscera organs present in the abdominal cavity at least for the time period corresponding to the time during which post-surgical adhesions are likely to occur. In particular, the structure of the second barrier layer of the prosthesis of the invention, which is formed of one or more flap members, allows creating protected spaces, adequate for positioning fixing means, such as clips, tacks, screws, spirals, straps, staples, suture or transfacial sutures, in a way that said fixing means are separate from the abdominal cavity, and in particular from the viscera organs present in said abdominal cavity, by a protective layer preventing adhesions at least for the time period corresponding to the time during which post-surgical adhesions are likely to occur after the implantation of the prosthesis, said protective layer being formed of the one or more flap members. Moreover, the fact that the second barrier layer is formed of one or more flap members provides for an easy access to said protected spaces for the surgeon. Thanks to the shape and nature of the second barrier layer of the prosthesis of the invention, the surgeon may easily fire fixing means, such as tacks, underneath the flap member(s), at the right position for fixing safely the prosthesis to the abdominal wall, and with limited risks that said fixing means further generate post-surgical adhesions with the organs of the abdominal cavity.
The prosthesis of the invention therefore allows completing intraperitoneal hernia repair with fewer risks of recurrence or of postoperative complications.
The prosthesis of the invention allows protecting the intestine and hollow organs of the abdominal cavity while efficiently strengthening the abdominal wall.
The prosthesis of the invention comprises at least one reinforcement layer, comprising a biocompatible porous material, said reinforcement layer including a first surface intended to face the abdominal wall and a second surface opposite said first surface. In embodiments, the reinforcement layer may consist in said biocompatible porous material.
The porous material suitable for the reinforcement layer of the prosthesis of the invention may comprise a sponge, a fibrous matrix or a combination of a sponge and of a fibrous matrix. For example, the sponge can be obtained by lyophilization of a gel, with pores being created during the lyophilization. The fibrous matrix can be any arrangement of yarns or yarn portions creating pores between the yarns and/or yarn portions. For example, the fibrous matrix can be a textile, for example obtained by knitting or weaving or according to a technique for producing a nonwoven.
In embodiments, the porous material, for example the sponge and/or the fibrous matrix, has pores with dimensions ranging from approximately 0.1 to approximately 3 mm.
In embodiment, the porous material comprises, preferably consists in, a mesh.
Within the meaning of the present application, a “mesh” is understood as an arrangement of biocompatible yarns, such as a knit, a woven fabric, a non-woven fabric, open-worked, that is to say provided with pores that favour recolonization of tissue. Such a mesh can be bioresorbable, permanent or partially bioresorbable. It is sufficiently flexible to be folded up and inserted into a trocar at the time of introduction into the abdominal cavity. The mesh can be made from one layer of textile or several layers of textiles. Such meshes are well known to a person skilled in the art. The mesh that can be used according to the invention can be supplied in any shape whatsoever, for example rectangular, square, circular, oval, etc., and can then be cut to suit the shape of the hernia defect. For example, the mesh can have a generally square shape or a rectangular shape. Alternatively, the overall shape of the mesh can be circular or oval.
In one embodiment of the invention, the mesh is a knit. By virtue of the meshwork of the knit, it is possible to obtain openworked faces that promote cell recolonization after implantation. The knit can be two-dimensional or three-dimensional.
Within the meaning of the present application, a two-dimensional knit is understood as a knit having two opposite faces linked to each other by meshes but devoid of a spacer giving it a certain thickness: such a knit can be obtained, for example, by knitting yarns on a warp knitting machine or raschel knitting machine using two guide bars. Examples of knitting two-dimensional knits suitable for the present invention are given in the document WO2009/071998.
According to the present application, a three-dimensional knit is understood as a knit having two opposite faces linked to each other by a spacer that gives the knit a significant thickness, said spacer itself being formed from additional linking yarns in addition to the yarns forming the two faces of the knit. Such a knit can be obtained, for example, on a double-bed warp knitting or raschel knitting machine using several guide bars. Examples of knitting three-dimensional knits suitable for the present invention are given in the documents WO99/05990, WO2009/031035 and WO2009/071998.
The porous material may comprise a bioresorbable or non-bioresorbable material.
In the present application, “bioresorbable” or “biodegradable” is understood to mean that the materials having this property are absorbed and/or degraded by the tissues or washed from the implantation site and disappear in vivo after a certain time, which may vary, for example, from a few hours to a few years, depending on the chemical nature of the materials.
The bioresorbable material suitable for the porous material of the reinforcement layer can be chosen from among the following bioresorbable materials: polylactic acid (PLA), polycaprolactones (PCL), polydioxanones (PDO), trimethylene carbonates (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoates (PHA), oxidized cellulose, polyglycolic acid (PGA), polyethylene glycol (PE), copolymers of these materials, and mixtures thereof.
The non-bioresorbable material suitable for the porous material of the reinforcement layer can be chosen from among the following non-bioresorbable materials: polypropylenes, polyesters such as polyethylene terephthalates, polyamides, silicones, polyether ether ketone (PEEK), polyarylether ether ketone (PAEK) and mixtures thereof.
In one embodiment of the invention, the reinforcement layer of porous material can be made from a gripping textile. Examples of gripping textile are described in the document WO/0181667. For example, with said gripping textile having a face provided with barbs, said face provided with barbs can be directed towards the biological tissues, for example the abdominal wall, for helping in the fixing of the prosthesis to the abdominal wall.
The reinforcement layer may exhibit any shape as long as said shape is large enough so as to cover efficiently the hernia defect to be treated.
In embodiments, said reinforcement layer has the shape of a rectangle, with or without rounded corners. In other embodiments, the reinforcement layer may have an oval shape. Such embodiments are suitable, for example, for the treatment of a ventral hernia. In embodiments, the reinforcement layer has the shape of a disc. Such an embodiment is suitable, for example, for the treatment of an umbilical hernia.
By virtue of its porous character, the reinforcement layer of the prosthesis of the invention is especially adapted to promote tissue ingrowth via its first surface after implantation. The cells of the abdominal wall deeply colonize the porous structure of the reinforcement layer via the first surface of the prosthesis.
The prosthesis of the invention further comprises at least a first barrier layer comprising a biocompatible anti-adhesion material, the first barrier layer including a first surface and a second surface opposite said first surface of the first barrier layer, the first surface of the first barrier layer covering substantially at least a central part of the area of the second surface of the reinforcement layer, the second surface of said first barrier layer being intended to face the abdominal cavity, said first barrier layer being delimited by a peripheral outer edge. In embodiments, the first barrier layer consists in said biocompatible anti-adhesion material.
The first barrier layer is positioned in the prosthesis of the invention so as to face the abdominal cavity and prevent the organs and other viscera of the abdominal cavity from attaching themselves at least to a central part of the prosthesis. The first barrier layer may adopt any shape, oval, circular, rectangular, etc. so as to substantially cover the central region of the second surface of the reinforcement layer. As will appear from the description below, the second barrier layer will cover the remaining part of the area of the second surface of the reinforcement layer, in other words the part of the area of the second surface of the reinforcement layer that is not covered by the first barrier layer, so that the entire area of the second surface of the reinforcement layer of the prosthesis is in the end covered by anti-adhesion material, either from the first barrier layer or from the second barrier layer.
In embodiments, the first barrier layer may cover the entire area of the second surface of the reinforcement layer. In embodiments, the first barrier layer may extend beyond the outer edge of the reinforcement layer, for example on a distance ranging from 3 mm to 7 mm. The viscera organs present in the abdominal cavity are therefore well prevented from contacting any porous material forming the reinforcement layer.
As seen above, the anti-adhesion material suitable for the first barrier layer is a biocompatible material that exhibits a continuous and smooth surface, for example non-porous, that minimizes tissue attachment by preventing providing space for cell recolonization, at least for the time period corresponding to the time during which post-surgical adhesions are likely to occur.
Such an anti-adhesion material makes it possible in particular to avoid the formation of undesirable and serious post-surgical fibrous adhesions, for example when the prosthesis is implanted in an intraperitoneal location.
The anti-adhesion material may be chosen from among bioresorbable materials, non-bioresorbable materials and mixtures thereof. The non-bioresorbable anti-adhesion materials can be selected from among polytetrafluoroethylene, polyethylene glycols, polysiloxanes, polyurethanes, and mixtures thereof.
Said anti-adhesion material is preferably bioresorbable: the bioresorbable materials suitable for said anti-adhesion material can be selected from among collagens, oxidized celluloses, polyethylene glycol, polyacrylates, trimethylene carbonates, caprolactones, dioxanones, butyric or glycolic acid, lactic acid, glycolides, lactides, polysaccharides, for example chitosans, polyglucuronic acids, hyaluronic acids, dextrans, polyvinyl alcohol, polypeptides, polymers, copolymers and mixtures thereof.
The anti-adhesion material suitable for the first barrier layer makes it possible to protect at least the central part, in embodiments the entire, area of the reinforcement layer of the prosthesis, at least during the initial phase of healing, that is to say the reinforcement layer is not exposed to inflammatory cells such as granulocytes, monocytes, macrophages or even the multi-nuclear giant cells that are generally activated by the surgery.
In the case where the anti-adhesion material is made of non-bioresorbable materials, it thus protects the reinforcement layer before and after implantation, throughout the period of implantation of the prosthesis.
Moreover, by virtue of the anti-adhesion material, the fragile surrounding tissues such as the hollow viscera, for example, are protected particularly from the formation of serious and undesirable post-surgical fibrous adhesions.
In the case where the anti-adhesion material comprises a bioresorbable material, it is preferable to choose a bioresorbable material that is resorbed only after a period of time ranging from a few days to a few weeks, so as to ensure that the anti-adhesion material can perform its function of protecting the intestine and the hollow organs during the days after the operation and until the cell recolonization of the prosthesis in turn protects the fragile organs.
The anti-adhesion material forming the first barrier layer may for example be provided as a coating or a film.
In embodiments, the first barrier layer is a coating. For example, a solution or suspension of an anti-adhesion material, for example polycaproplactone, is prepared by solubilising said anti-adhesion material in a solvent. The solution or suspension may then be applied on the part of the area of the second surface of the reinforcement layer that is intended to be covered by the first barrier layer, for example at least a central part of the area of said second surface or alternatively the entire area of said second surface. For example, the solution or suspension may be sprayed over the area to be coated in order to form a homogeneous coating. The spraying step may be repeated until the desired amount of material is deposed on the second surface of the reinforcement layer. The solvent may be evaporated during the coating process.
In other embodiments, the first barrier layer may be under the form of a film of anti-adhesion material that is further applied on the area of the second surface of the reinforcement layer to be covered.
For example, a film suitable for the first barrier layer of the prosthesis of the invention is described in U.S. Pat. No. 6,235,869 and may be prepared as follows : a copolymer of glycolide, lactide, trimethylene carbonate and e-caprolactone is synthetized and provided under the form of pellets. The pellets are melt and extruded as a film with a controlled thickness. For example, the film thickness is between 0.5 to 1.2 mil.
The film may be applied on the second surface of the reinforcement layer as follows : the reinforcement layer is placed in a lamination equipment with its second surface at the top. The film prepared as above described is positioned upon the second surface of the reinforcement layer on the part of the area of the second surface of the reinforcement layer that is intended to be covered by the first barrier layer, for example at least a central part of the area of said second surface or alternatively the entire area of said second surface. The assembly may then be pressed under controlled conditions of temperature and pressure so as to laminate the film on the second surface of the reinforcement layer.
The prosthesis of the invention further comprises at least a second barrier layer, said second barrier layer being shaped and dimensioned so as to cover at least the part of the area of the second surface of said reinforcement layer that is not covered by the first barrier layer, said second barrier layer comprising one or more flap members, each flap member being formed of a piece of sheet of biocompatible anti-adhesion material, and having at least an outer edge attached to the second surface of the reinforcement layer and a free inner edge.
In the present application, by “flap member” is meant a piece of sheet of biocompatible anti-adhesion material having any shape, such as rectangular, annular, triangular, square, said shape defining an outer edge and an inner edge of said flap member, said outer edge being attached to the second surface of the reinforcement layer, said inner edge being left free, so that the flap member is able to adopt a rest configuration, in which the piece of sheet is substantially parallel to the reinforcement layer, with the inner edge of the flap member being in the direction of the centre of the reinforcement layer, and a lifted configuration, in which the inner edge of the flap member is pulled away from the reinforcement layer.
In embodiments, the second barrier layer consists in said one or more flap members.
The areas of the pieces of sheet of biocompatible anti-adhesion material of the flap member(s) forming the second barrier layer amount altogether, in a rest configuration of the flap members, namely parallel to the reinforcement layer, to a total area corresponding to at least the area of the second surface of the reinforcement layer that is not covered by the first barrier layer, also hereinafter referred to as the “remaining area”. Some of the flap members may overlap with others. In any case, the second barrier layer being shaped and dimensioned so as to cover at least the part of the area of the second surface of the reinforcement layer that is not covered by the first barrier layer, in the end, the whole surface of the “remaining area” is safely covered by anti-adhesion material. As a result, the entire area of the second surface of the reinforcement layer is covered by anti-adhesion material, coming either from the first barrier layer or from the second barrier layer.
In embodiments, the area resulting from the addition of the areas of the one or more flap member(s) is less than 120% of the area of the second surface of said reinforcement layer that is not covered by the first barrier layer, namely the remaining area. Implantation of excess foreign material within the body of the patient is therefore avoided, while ensuring that the entire area of the second surface of the reinforcement layer is safely covered by anti-adhesion material.
The flap member(s) of the second barrier layer is/are further intended to cover the proximal ends of the fixing means, for example the heads of the tacks, that will be fired through the reinforcement layer in a view of fixating the prosthesis to the abdominal wall. The piece of sheet of anti-adhesion material forming one flap member is therefore preferably shaped and dimensioned so as to cover entirely at least the proximal end of one fixing means, for example the head of a tack, that will protrude from the prosthesis once the prosthesis is fixed to the abdominal wall. In embodiments, one flap member may be formed of a piece of sheet shaped and dimensioned so as to cover a plurality of fixing means, in particular the proximal ends of said fixing means, such as tacks' heads, protruding out of the second surface of the reinforcement layer once the prosthesis is fixed to the abdominal wall.
In this application, the distal end of a device must be understood as meaning the end furthest from the hand of the user and the proximal end must be understood as meaning the end closest to the hand of the user.
For example, whatever the shape of the piece of sheet forming a flap member, it is recommended that the smallest dimension of said shape correspond at least to twice the length of the fixing means used to fixate the prosthesis to the abdominal wall, for example twice the length of the tack used.
In embodiments, the smallest dimension of the shape of the piece of sheet of anti-adhesion material forming a flap member ranges from about 1 cm to 4 cm, preferably from 2 cm to 3 cm.
In embodiments, the second barrier layer comprises at least a first flap member having the form of an annular band, the outer edge of said first flap member being substantially attached to the second surface of the reinforcement layer along the outer edge of said reinforcement layer.
The position of the attaching line of the outer edge of the first flap member may vary between the outer edge of the reinforcement barrier layer and a line offset slightly from said outer edge, towards the center of the prosthesis, this attaching line being substantially parallel to the outer edge of the reinforcement layer.
The inner edge of the first flap member being free, the first flap member forms a sort of skirt attached along the outer edge of the reinforcement layer, said skirt allowing access to an annular protected space defined between the skirt and the reinforcement layer. At the time of fixating the prosthesis to the abdominal wall, the surgeon will be able to gain access easily to the protected space by lifting the free inner edge of the skirt shaped flap member, to introduce the fixating tool therein and fire therein the tacks. As a result, the heads of the tacks will be covered by the skirt formed by the first flap member, namely by the anti-adhesion material piece of sheet forming the first flap member, so that the heads of the implanted tacks will not be in contact with the surrounding biological organs, at least during the time period corresponding to the time during which post-surgical adhesions are likely to occur. Because of the annular band shape of the skirt shaped flap member, the surgeon will be able to fire tacks all along the perimeter of the reinforcement layer and will be able to distribute the tacks as desired along this perimeter for an optimal fixation.
Because of the fact that the first flap member forming the second barrier layer is attached to the reinforcement layer along the outer edge of the reinforcement layer, for example at a distance of about 1 cm from the outer edge of the reinforcement layer, the surgeon can safely push the fixating tool to the very end of the protected space, at the location where the second barrier layer and the reinforcement layer are attached together, and fire the tack so as to fix the reinforcement layer to the abdominal wall. The surgeon may repeat this step as many times as needed all along the periphery of the line attaching the second barrier layer to the reinforcement layer. Suitable fixing means include resorbable or non-resorbable clips, tacks, screws, spirals, straps, staples, suture or transfacial sutures. Thus, the surgeon is assured of fixing the prosthesis to the biological tissues, for example the abdominal wall or peritoneum, without any risk of touching and/or stapling the surrounding organs, for example the intestines.
Moreover, once the surgeon has fixed the reinforcement layer of the prosthesis to the abdominal wall and the fixing tool has been removed from the implantation site, the heads of the tacks which have been positioned for fixing the prosthesis to the abdominal wall are located in the protected space delimited inbetween the second barrier layer and the reinforcement layer. As a consequence, the heads of the tacks are covered by the second barrier layer, in particular by the flap member(s) forming the second barrier layer, and are not in contact with the viscera organs present in the abdominal cavity.
In embodiments, said second barrier layer consists in said first flap member having the form of an annular band, the outer edge of said first flap member being substantially attached to the second surface of the reinforcement layer along the outer edge of said reinforcement layer. As described above, in such a case, the first flap member covers at least the part of the area of the second surface of said reinforcement layer that is not covered by the first barrier layer, namely the remaining area. In embodiments, the first flap member may have an area greater than the remaining area and it may therefore overlap a part of the first barrier layer. In any case, the entire area of the second surface of the reinforcement layer is covered by anti-adhesion material.
In other embodiments, the second barrier layer further comprises at least a second flap member in addition to said first flap member, the outer edge of said second flap member being substantially attached to the second surface of the reinforcement layer along a line located between the outer edge of the reinforcement layer and the outer edge of the first barrier layer. The presence of additional flap members allows creating additional protected spaces for firing fixing means, for a reinforced fixation. The additional flap members may be positioned in function of the location of the reinforcement layer where a reinforced fixation may be needed. Reinforced fixations may be needed for example in case of large prosthesis intended to be implanted in obese patients.
For example, the second barrier layer may consist in a first flap member having the form of a first annular band, the outer edge of said first flap member being substantially attached to the second surface of the reinforcement layer along the outer edge of said reinforcement layer, and in a second flap member, said second flap member having the form of a second annular band, said first and second flap members being concentrically positioned one with respect to the other, so that the outer edge of said second flap member is substantially attached to the second surface of the reinforcement layer along a line substantially parallel to the outer edge of the reinforcement layer, said line being located between the outer edge of the reinforcement layer and the outer edge of the first barrier layer.
As described above, in such a case, the first flap member and the second flap member cover at least the part of the area of the second surface of said reinforcement layer that is not covered by the first barrier layer, namely the remaining area. In embodiments, the first flap member and the second flap member may together totalize an area greater than the remaining area. For example, the free inner edge of the first flap member may overlap the attached outer edge of the second flap member, and the free inner edge of the second flap member may overlap the outer edge of the first barrier layer. In any case, the entire area of the second surface of the reinforcement layer is covered by anti-adhesion material.
In such embodiments, the second flap member defines a second skirt, in addition to the first skirt defined by the first flap member, allowing access to a second annular protected space defined between the second skirt and the reinforcement layer, concentrically located with the first annular protected space created by the first flap member in the direction of the center of the reinforcement layer.
Such embodiments allow the surgeon to position a first line of tacks at the location of the first protected space and a second line of tacks at the location of the second protected space, for example for a reinforced fixation of the prosthesis.
Alternatively, for example, the second barrier layer may consist in a first flap member having the form of an annular band, the outer edge of said first flap member being substantially attached to the second surface of the reinforcement layer along the outer edge of said reinforcement layer, and in a second and a third flap members, each of said second and third flap members having the form of a tape portion, the respective outer edges of said second and third flap members being substantially attached to the second surface of the reinforcement layer along line(s) located between the outer edge of the reinforcement layer and the outer edge of the first barrier layer, said line(s) being intended to be positioned in regards of the vicinity of the edges of the hernia defect.
Such embodiments allow proceeding to a fixation technique where additional tacks may be positioned at the vicinity of the edges of the defect to be treated.
In embodiments, the outer edge of said first flap member is attached along the outer edge of said reinforcement layer in a continuous way. The surgeon therefore knows that he can apply the tacks or the staples at any point in the space created inbetween the first flap member and the reinforcement layer, without having to look for a precise location.
In embodiments, the outer edge of said first flap member is attached to the second surface of the reinforcement layer so as to define an attaching line which is offset towards a center of the prosthesis from about 0.5 to about 2 cm, preferably about 1 cm, from the outer edge of said reinforcement layer. Such embodiments allow ensuring that the fixing means, such as the clips, tacks, screws, spirals, straps, staples, suture or transfacial sutures, will not move closer to the outer edge of the prosthesis and in particular of the reinforcement layer, than 1 cm. The surgeon is therefore ensured that the fixing means will be positioned so as to guaranty an efficient fixing. It may then be useful that the first barrier layer covers the entire area of the second surface of the reinforcement layer, and optionally goes beyond the outer edge of the reinforcement layer, to ensure that the entire area of the second surface of the reinforcement layer is covered by anti-adhesion material.
In embodiments, said first barrier layer covering the entire area of the second surface of the reinforcement layer, the outer edge(s) of the flap member(s) forming the second barrier layer is/are attached to the second surface of the reinforcement layer via the intermediate of the first barrier layer.
In embodiments, the outer edge(s) of the flap member(s) forming the second barrier layer is/are attached to the second surface of the reinforcement layer by attaching means selected from the group comprising ultrasonic welding, hot compression welding, gluing and combinations thereof.
For example, when the first barrier layer is intended to cover the entire area of the second surface of the reinforcement layer and when the second barrier layer is intended to consist in one flap member having the form of an annular band, the first and second barrier layers may be attached one to the other in a separate step, the assembly of the two attached layers being thereafter attached to the reinforcement layer.
The step of attaching the first barrier layer to the second barrier layer may be performed by ultrasonic welding as follows: a layer of the first barrier layer is placed on an ultrasonic press anvil, the anvil being protected by a peelable film of a polymer having a melting point higher than the temperature intented to be set for the lamination step, said peelable film being intended to prevent the welding of the first barrier layer on the ultrasonic press anvil. A second peelable film of the same polymer, shaped into a similar but smaller shape than the future first barrier layer, is laid on the first barrier layer so as to let non protected only a peripheral region of the first barrier layer.
The annular band shaped second barrier layer is placed onto the second peelable film, so as to overlap both the unprotected peripheral region of the first barrier layer and a peripheral region of the second peelable film. A third peelable film of the same polymer as above, having the same shape of the second barrier layer is laid on the top of the second barrier layer to prevent the welding of the second barrier layer on the ultrasonic press sonotrod.
The sonotrod of the ultrasonic welding press is lowered to press the second barrier layer onto the first barrier layer. Ultrasonic vibration is applied, and the second barrier layer is welded to the future first barrier layer in the peripheral region of the first barrier layer.
The first peelable film is removed, and the assembly of the first and second barrier layers is afterward placed on the second surface of the reinforcement layer coated with a polymer glue.
A hot press is then used to apply a pressure onto the three layers so as to hotmelt the gluing polymer coating and glue the first barrier layer onto the reinforcement layer. Because of the presence of the second and third peelable antiadhesion films, the second barrier layer is prevented to adhere onto the first barrier layer and onto the hot press.
By removing the second and third peelable films, a prosthesis of the invention is obtained, in which the first barrier layer covers the entire area of the second surface of the reinforcement layer and the second barrier is an annular band shaped flap member, the outer edge of which is attached to the first barrier layer and therefore to the reinforcement layer. In other words, the outer edge of the second barrier layer is attached to the reinforcement layer via the intermediate of the first barrier layer.
In the prosthesis of the invention, the second barrier layer is strongly assembled with the first barrier layer and/or the reinforcement layer and the integrity of the assembly is not compromised by the movement of the tacker shaft in the protected space created by the second barrier layer at the moment the surgeon proceeds to the fixing of the prosthesis to the abdominal wall.
The anti-adhesion material suitable for forming the second barrier layer may be defined in the same way as the anti-adhesion material defined above for the first barrier layer. The anti-adhesion material used for forming the second barrier layer may be identical or different from that used for forming the first barrier layer. Moreover, the anti-adhesion material used for forming the flap member(s) of the second barrier layer may be identical or different from one flap member to the other.
The anti-adhesion material forming the flap members(s) of the second barrier layer makes it possible to protect at least the remaining area, in other words, the part of the area of the second surface of said reinforcement layer that is not covered by the first barrier layer, at least during the initial phase of healing, that is to say the reinforcement layer is not exposed to inflammatory cells such as granulocytes, monocytes, macrophages or even the multi-nuclear giant cells that are generally activated by the surgery.
Indeed, at least during the initial phase of healing, the duration of which can vary between 5 and 10 days approximately, only the anti-adhesion material of the first barrier layer and of the second barrier layer can be accessed by the various factors such as proteins, enzymes, cytokines or cells of the inflammatory line.
For example, the flap member(s) forming the second barrier layers may be pieces of films of anti-adhesion material as described above for the first barrier layer.
In embodiments, said second barrier layer is provided with markings intended to indicate to the surgeon where to locate one or more fixing means for fixing the prosthesis to the abdominal wall. For example, said markings may be under the form of colored spots located on the surface of said second barrier layer intended to face the abdominal cavity. In embodiments, the markings, such as colored spots, are regularly spaced from one another along a perimeter of said second barrier layer. For example, the markings are distant 1.5 cm from one another. Such embodiments allow the surgeon to easily position the fixing means, such as tacks, at intervals of 1.5 cm. Such a fixation technique is usually associated with a low recurrence rate of the hernia (see Bittner, R., et al., Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias (International Endohernia Society (IEHS)—Part 1. Surgical Endoscopy, 2014. 28(1): p. 2-29)
In embodiments, the second barrier layer may be provided with identification means for distinguishing said second barrier layer from said first barrier layer. For example, the second barrier layer may show a color different than that of the first barrier layer. In other examples, the second barrier layer may be provided with specific designs drawn on flap member(s), such as geometric figures, etc . . .
In embodiments, the free inner edge(s) of said flap member(s) forming the second barrier layer is/are provided with one or more projecting tab(s) intended to help the surgeon lift said flap member(s) from said reinforcement layer. Such embodiments allow the surgeon lift easily the flap member in order to introduce the fixing means within the protected space formed between the flap member and the reinforcement layer. The gesture of the surgeon is therefore facilitated.
In embodiments, the flap member(s) forming the second barrier layer is/are provided on their surface regarding the reinforcement layer or the first barrier layer with a tacky layer of biocompatible materials capable of sticking to said reinforcement layer or first barrier layer. It is therefore possible to stick the flap member(s) to the reinforcement layer or first barrier layer once the fixing means has been positioned, the flap member(s) thereby covering the proximal ends of the fixing means with reinforced safety. The biocompatible materials suitable for forming the tacky layer may be selected from collagen-based, polylactone-based, polylactic, polyethylene glycol, polysaccharides and/or polyvinyl alcohol based surgical adhesives, fibrin glues, and combinations thereof.
Another aspect of the invention is a method for treating a hernia defect, in particular a ventral hernia defect, comprising the following steps :
The present invention will become clearer from the following description and from the attached drawings, in which:
With reference to
The reinforcement layer 2 is made of a biocompatible porous material, in particular capable of promoting tissue ingrowth. The reinforcement layer may be under the form of a sponge, for example obtained by lyophilisation of a polymeric composition, a fibrous matrix such as a textile or combinations thereof. The reinforcement layer preferably shows mechanical properties allowing it to perform its function of strengthening and repairing the abdominal wall.
Reinforcement layers are well known in the art. In embodiments, the reinforcement layer may be a textile, such as a bidimensional porous knit or a three-dimensional porous knit.
With reference to
The reinforcement layer 2 has a first surface 2a and a second surface 2b, opposite the first surface. On the example shown, the first surface 2a is intended to face the abdominal wall (see
The prosthesis 1 further comprises a first barrier layer, under the form of a film 3 on the example shown. The first barrier layer or film 3 is made of a biocompatible anti-adhesion material. The film 3 shows a first surface 3a and a second surface 3b, opposite the first surface 3a. The first barrier layer or film 3 is delimited by an outer edge 3c.
The anti-adhesion material forming the first barrier layer or film 3 allows preventing post surgical adhesions between the viscera organs of the abdominal cavity and the porous material forming the reinforcement layer 2. The first surface of the first barrier layer, such as the film 3, covers at least a central part of the area of the second surface 2b of the reinforcement layer 2. In the example shown on
In other embodiments (see
The anti-adhesion material may be chosen from among bioresorbable materials, non-bioresorbable materials and mixtures thereof. The non-bioresorbable anti-adhesion materials can be selected from among polytetrafluoroethylene, polyethylene glycols, polysiloxanes, polyurethanes, and mixtures thereof.
The anti-adhesion material is preferably bioresorbable: the bioresorbable materials suitable for said anti-adhesion material can be selected from among collagens, oxidized celluloses, polyethylene glycol, polyacrylates, trimethylene carbonates, caprolactones, dioxanones, butyric or glycolic acid, lactic acid, glycolides, lactides, polysaccharides, for example chitosans, polyglucuronic acids, hyaluronic acids, dextrans, and mixtures thereof.
For example, the film 3 of
In other embodiments, the film 3 may be a non porous collagen film or a bioabsorbable collagen film based on oxidized collagen with polyethylene glycol. Such films based on collagen may be obtained by application on the second surface of the reinforcement layer of a solution based on collagen and by gelification of the solution thereon.
In other embodiments, the first barrier layer is a coating obtained by spraying a solution or a suspension of an anti-adhesion material on the second surface of the reinforcement layer 2.
The prosthesis 1 further comprises a second barrier layer, consisting in a flap member under the form of a first skirt 4 on
The anti-adhesion material forming the second barrier layer, namely the first skirt 4, may be chosen among the same materials as described above for the anti-adhesion material forming the first barrier layer. The anti-adhesion material forming the first skirt 4 may be identical or different than the anti-adhesion material forming the film 3.
For example, the first skirt 4 is made of a film of a copolymer of glycolide, lactide, trimethylene carbonate and e-caprolactone, the preparation of which is described in U.S. Pat. No. 6,235,869.
The first skirt 4 has an outer edge 5a and an inner edge 5b. The annular band forming the first skirt 4 has preferably a width, corresponding to the length measured along a direction aligned on a radius of the reinforcement layer extending from the center C of the reinforcement layer to a point of the outer edge of the reinforcement layer, ranging from about 1 cm to 4 cm, preferably from 2 cm to 3 cm. The first skirt 4 is therefore particularly adapted for covering the proximal ends of the fixing means used for fixing the prosthesis 1 to the abdominal wall.
The first skirt 4 further shows a first surface 4a, intended to face the first barrier layer or film 3, and a second surface 4b intended to face the abdominal cavity (see
In the example shown, with reference to
Preferably, the outer edge 5a of the first skirt 4 is attached along the outer edge 3c of the film 3 in a continuous way. For example, the outer edge 5a of the first skirt 4 is attached to the film 3 so as to define an attaching line 6 which is offset towards a center of the prosthesis from about 0.5 to about 2 cm, preferably about 1 cm, from said outer edge. As will appear from the description of
The first barrier layer, such as the film 3, and the second barrier layer, such as the first skirt 4, may be attached one to the other by attaching means selected from the group comprising ultrasonic welding, hot compression welding, gluing and combinations thereof.
For example, in case the anti-adhesion material forming the first and second barrier layers is selected from polylactic acid, polyglycolic acid, trimethylene carbonates, polyethylene glycol, polycaprolactone, and combinations thereof, the first barrier layer and the second barrier layer may be attached one to the other via ultrasonic welding by applying pressure and piezo energy to ensure local fusion of the two barriers.
Alternatively, in case the anti-adhesion material forming the first and second barrier layers is a collagen or derivatives thereof, the first barrier layer and the second barrier layer may be attached one to the other via a gluing agent, for example a gluing agent capable of locally solubilising both barriers in order to fusion them. The gluing agent may be a collagen water solution, with or without a crosslinking agent. For example, in contact with such a collagen water solution, the first and second barriers' surfaces will tend to melt, and by a drying process the first and second barriers will be unified.
For example, in the present example, the film 3 and the first skirt 4 being each made of a film of a copolymer of glycolide, lactide, trimethylene carbonate and e-caprolactone, the first skirt 4 is attached to the film 3 by ultrasonic welding. The first skirt 4 is therefore securely attached to the film 3.
As shown on
With reference to
With reference to
In embodiments, the markings are distant 1.5 cm from one another. Such embodiments allow the surgeon to easily position the fixing means, such as tacks, at intervals of 1.5 cm. Such a fixation technique is usually associated with a low recurrence rate of the hernia.
Alternatively, markings, such as a dotted line, may be provided on the reinforcement layer 2 itself.
In embodiments, the second barrier layer or first skirt 4 may be provided with identification means for distinguishing said first skirt 4 from said first barrier layer or film 3. For example, the first skirt 4 may show a color different than that of the film 3. In other embodiments, the first skirt 4 may be provided with specific designs drawn on flap member(s), such as geometric figures, etc . . .
With reference to
In embodiments not shown, the first skirt 4 could be provided with one or more tabs, positioned anywhere along the length of its inner edge, for example positioned along the mid-line of a side of the inner edge where a minimal amount of force will create a greater separation between the first skirt 4 and the reinforcement layer 2 along that side of the first skirt 4.
With reference to
For example, the second skirt 9 is made of a film of a copolymer of glycolide, lactide, trimethylene carbonate and e-caprolactone, the preparation of which is described in U.S. Pat. No. 6,235,869.
In the Example shown on
Moreover, as shown on
The second skirt 9 may be attached to the film 3 and to the first skirt 4 by the same methods as described above for attaching the film 3 to the first skirt 4. For example, in the present example, the film 3, the second skirt 9 and the first skirt 4 being each made of a film of a copolymer of glycolide, lactide, trimethylene carbonate and e-caprolactone, the first skirt 4, second skirt 9 and film 3 may be attached altogether by ultrasonic welding. The first skirt 4, second skirt and film 3 are therefore securely attached together.
As shown on
With reference to
As appears from
Such embodiments of the prosthesis 1 of the invention as shown on
With reference to
Such embodiment allows creating two longitudinal protected spaces 15, located between the film 3 and the tape portions 14, for lodging fixing means, such as tacks, in the vicinity of the defect edges.
The method of treating a hernia defect with the prosthesis 1 of
The surgeon then moves the prosthesis 1 closer to the peritoneum 104/abdominal wall 101 so that the first surface 2a of the prosthesis 1 bears on the peritoneum 104/abdominal wall 101; the surgeon grasps the inner perimeter 5b of the first skirt 4 with a laparoscopic tool so as to lift the first skirt 4 and gain access to the protected space 11. A tacker 17 is then introduced in the abdominal cavity 109 by means of a trocar (not shown). The distal end of the tacker 17 is introduced in the protected space 11 and a tack 16 is fired in the direction of the peritoneum 104/abdominal wall 101, as shown on
In embodiments where the attaching line 6 of the prosthesis 1 is continuous and offset towards the center of the prosthesis 1 from the outer edge 3c of the first barrier layer of film 3, as shown on
The same operation is repeated for each tack 16, as many times as deemed necessary by the surgeon in order to obtain an efficient fixation of the prosthesis 1 to the peritoneum 104/abdominal wall 101.
With reference to
As a result, the risk of recurrence provoked by the formation of post-surgical adhesions between the fixing means, such as tacks 16, and the viscera organs of the abdominal cavity 109 is dramatically decreased with the prosthesis 1 of the invention.
In embodiments, the first skirt 4 is provided on its surface regarding the film 3 with a tacky layer of biocompatible materials, and the surgeon may cover the head 16a of each tack 16 and then stick the first skirt 4 to the film 3 for a reinforced protection and reliable separation of the tack's head from the surrounding biological issues of the abdominal cavity.
The prosthesis of the invention therefore allows completing intraperitoneal repair with fewer risks of recurrence or of postoperative complications.
| Number | Date | Country | Kind |
|---|---|---|---|
| 16305063 | Jan 2016 | EP | regional |
| Number | Name | Date | Kind |
|---|---|---|---|
| 1187158 | Mcginley | Jun 1916 | A |
| 3054406 | Usher | Sep 1962 | A |
| 3118294 | Van Laethem | Jan 1964 | A |
| 3124136 | Usher | Mar 1964 | A |
| 3272204 | Charles et al. | Sep 1966 | A |
| 3276448 | Usher | Oct 1966 | A |
| 3320649 | Naimer | May 1967 | A |
| 3364200 | Ashton et al. | Jan 1968 | A |
| 3570482 | Emoto et al. | Mar 1971 | A |
| 3718725 | Hamano | Feb 1973 | A |
| 4006747 | Kronenthal et al. | Feb 1977 | A |
| 4060081 | Yannas et al. | Nov 1977 | A |
| 4173131 | Pendergrass et al. | Nov 1979 | A |
| 4193137 | Heck | Mar 1980 | A |
| 4248064 | Odham | Feb 1981 | A |
| 4294241 | Miyata | Oct 1981 | A |
| 4307717 | Hymes et al. | Dec 1981 | A |
| 4338800 | Matsuda | Jul 1982 | A |
| 4476697 | Schafer et al. | Oct 1984 | A |
| 4487865 | Balazs et al. | Dec 1984 | A |
| 4500676 | Balazs et al. | Feb 1985 | A |
| 4511653 | Play et al. | Apr 1985 | A |
| 4527404 | Nakagaki et al. | Jul 1985 | A |
| 4591501 | Cioca | May 1986 | A |
| 4597762 | Walter et al. | Jul 1986 | A |
| 4603695 | Ikada et al. | Aug 1986 | A |
| 4631932 | Sommers | Dec 1986 | A |
| 4670014 | Huc et al. | Jun 1987 | A |
| 4709562 | Matsuda | Dec 1987 | A |
| 4748078 | Doi et al. | May 1988 | A |
| 4759354 | Quarfoot | Jul 1988 | A |
| 4769038 | Bendavid et al. | Sep 1988 | A |
| 4796603 | Dahlke et al. | Jan 1989 | A |
| 4813942 | Alvarez | Mar 1989 | A |
| 4841962 | Berg et al. | Jun 1989 | A |
| 4854316 | Davis | Aug 1989 | A |
| 4925294 | Geshwind et al. | May 1990 | A |
| 4931546 | Tardy et al. | Jun 1990 | A |
| 4942875 | Hlavacek et al. | Jul 1990 | A |
| 4948540 | Nigam | Aug 1990 | A |
| 4950483 | Ksander et al. | Aug 1990 | A |
| 4970298 | Silver et al. | Nov 1990 | A |
| 4976737 | Leake | Dec 1990 | A |
| 5002551 | Linsky et al. | Mar 1991 | A |
| 5015584 | Brysk | May 1991 | A |
| 5116357 | Eberbach | May 1992 | A |
| 5147374 | Fernandez | Sep 1992 | A |
| 5162430 | Rhee et al. | Nov 1992 | A |
| 5171273 | Silver et al. | Dec 1992 | A |
| 5176692 | Wilk et al. | Jan 1993 | A |
| 5192301 | Kamiya et al. | Mar 1993 | A |
| 5195542 | Gazielly et al. | Mar 1993 | A |
| 5196185 | Silver et al. | Mar 1993 | A |
| 5201745 | Tayot et al. | Apr 1993 | A |
| 5201764 | Kelman et al. | Apr 1993 | A |
| 5206028 | Li | Apr 1993 | A |
| 5217493 | Raad et al. | Jun 1993 | A |
| 5254133 | Seid | Oct 1993 | A |
| 5256418 | Kemp et al. | Oct 1993 | A |
| 5258000 | Gianturco | Nov 1993 | A |
| 5263983 | Yoshizato et al. | Nov 1993 | A |
| 5304595 | Rhee et al. | Apr 1994 | A |
| 5306500 | Rhee et al. | Apr 1994 | A |
| 5324775 | Rhee et al. | Jun 1994 | A |
| 5328955 | Rhee et al. | Jul 1994 | A |
| 5334527 | Brysk | Aug 1994 | A |
| 5339657 | McMurray | Aug 1994 | A |
| 5350583 | Yoshizato et al. | Sep 1994 | A |
| 5356432 | Rutkow et al. | Oct 1994 | A |
| 5368549 | McVicker | Nov 1994 | A |
| 5368602 | de la Torre | Nov 1994 | A |
| 5370650 | Tovey et al. | Dec 1994 | A |
| 5376375 | Rhee et al. | Dec 1994 | A |
| 5376376 | Li | Dec 1994 | A |
| 5397331 | Himpens et al. | Mar 1995 | A |
| 5399361 | Song et al. | Mar 1995 | A |
| 5413791 | Rhee et al. | May 1995 | A |
| 5425740 | Hutchinson, Jr. | Jun 1995 | A |
| 5428022 | Palefsky et al. | Jun 1995 | A |
| 5433996 | Kranzler et al. | Jul 1995 | A |
| 5441491 | Verschoor et al. | Aug 1995 | A |
| 5441508 | Gazielly et al. | Aug 1995 | A |
| 5456693 | Conston et al. | Oct 1995 | A |
| 5456711 | Hudson | Oct 1995 | A |
| 5466462 | Rosenthal et al. | Nov 1995 | A |
| 5480644 | Freed | Jan 1996 | A |
| 5487895 | Dapper et al. | Jan 1996 | A |
| 5490984 | Freed | Feb 1996 | A |
| 5512291 | Li | Apr 1996 | A |
| 5512301 | Song et al. | Apr 1996 | A |
| 5514181 | Light et al. | May 1996 | A |
| 5522840 | Krajicek | Jun 1996 | A |
| 5523348 | Rhee et al. | Jun 1996 | A |
| 5536656 | Kemp et al. | Jul 1996 | A |
| 5543441 | Rhee et al. | Aug 1996 | A |
| 5565210 | Rosenthal et al. | Oct 1996 | A |
| 5567806 | Abdul-Malak et al. | Oct 1996 | A |
| 5569273 | Titone et al. | Oct 1996 | A |
| RE35399 | Eisenberg | Dec 1996 | E |
| 5593441 | Lichtenstein et al. | Jan 1997 | A |
| 5595621 | Light et al. | Jan 1997 | A |
| 5601571 | Moss | Feb 1997 | A |
| 5607474 | Athanasiou et al. | Mar 1997 | A |
| 5607590 | Shimizu | Mar 1997 | A |
| 5614587 | Rhee et al. | Mar 1997 | A |
| 5618551 | Tardy et al. | Apr 1997 | A |
| 5634931 | Kugel | Jun 1997 | A |
| 5639796 | Lee | Jun 1997 | A |
| 5665391 | Lea | Sep 1997 | A |
| 5667839 | Berg | Sep 1997 | A |
| 5676967 | Williams et al. | Oct 1997 | A |
| 5681568 | Goldin et al. | Oct 1997 | A |
| 5686090 | Schilder et al. | Nov 1997 | A |
| 5686115 | Voumakis et al. | Nov 1997 | A |
| 5690675 | Sawyer et al. | Nov 1997 | A |
| 5695525 | Mulhauser et al. | Dec 1997 | A |
| 5697978 | Sgro | Dec 1997 | A |
| 5700476 | Rosenthal et al. | Dec 1997 | A |
| 5700477 | Rosenthal et al. | Dec 1997 | A |
| 5702416 | Kieturakis et al. | Dec 1997 | A |
| 5709934 | Bell et al. | Jan 1998 | A |
| 5711960 | Shikinami | Jan 1998 | A |
| 5716409 | Debbas | Feb 1998 | A |
| 5720981 | Eisinger | Feb 1998 | A |
| 5732572 | Litton | Mar 1998 | A |
| 5743917 | Saxon | Apr 1998 | A |
| 5749895 | Sawyer et al. | May 1998 | A |
| 5752974 | Rhee et al. | May 1998 | A |
| 5766246 | Mulhauser et al. | Jun 1998 | A |
| 5766631 | Arnold | Jun 1998 | A |
| 5769864 | Kugel | Jun 1998 | A |
| 5771716 | Schlussel | Jun 1998 | A |
| 5785983 | Furlan et al. | Jul 1998 | A |
| 5800541 | Rhee et al. | Sep 1998 | A |
| 5814328 | Gunasekaran | Sep 1998 | A |
| 5833705 | Ken et al. | Nov 1998 | A |
| 5840011 | Landgrebe et al. | Nov 1998 | A |
| 5861034 | Taira et al. | Jan 1999 | A |
| 5863984 | Doillon et al. | Jan 1999 | A |
| 5869080 | McGregor et al. | Feb 1999 | A |
| 5871767 | Dionne et al. | Feb 1999 | A |
| 5876444 | Lai | Mar 1999 | A |
| 5891558 | Bell et al. | Apr 1999 | A |
| 5899909 | Claren et al. | May 1999 | A |
| 5906937 | Sugiyama et al. | May 1999 | A |
| 5910149 | Kuzmak | Jun 1999 | A |
| 5911731 | Pham et al. | Jun 1999 | A |
| 5916225 | Kugel | Jun 1999 | A |
| 5919232 | Chaffringeon et al. | Jul 1999 | A |
| 5919233 | Knopf et al. | Jul 1999 | A |
| 5922026 | Chin | Jul 1999 | A |
| 5931165 | Reich et al. | Aug 1999 | A |
| 5942278 | Hagedorn et al. | Aug 1999 | A |
| 5962136 | Dewez et al. | Oct 1999 | A |
| 5972022 | Huxel | Oct 1999 | A |
| RE36370 | Li | Nov 1999 | E |
| 5993844 | Abraham et al. | Nov 1999 | A |
| 5994325 | Roufa et al. | Nov 1999 | A |
| 5997895 | Narotam et al. | Dec 1999 | A |
| 6001895 | Harvey et al. | Dec 1999 | A |
| 6008292 | Lee et al. | Dec 1999 | A |
| 6015844 | Harvey et al. | Jan 2000 | A |
| 6039686 | Kovac | Mar 2000 | A |
| 6042534 | Gellman et al. | Mar 2000 | A |
| 6042592 | Schmitt | Mar 2000 | A |
| 6043089 | Sugiyama et al. | Mar 2000 | A |
| 6051425 | Morota et al. | Apr 2000 | A |
| 6056688 | Benderev et al. | May 2000 | A |
| 6056970 | Greenawalt et al. | May 2000 | A |
| 6057148 | Sugiyama et al. | May 2000 | A |
| 6063396 | Kelleher | May 2000 | A |
| 6066776 | Goodwin et al. | May 2000 | A |
| 6066777 | Benchetrit | May 2000 | A |
| 6071292 | Makower et al. | Jun 2000 | A |
| 6077281 | Das | Jun 2000 | A |
| 6080194 | Pachence et al. | Jun 2000 | A |
| 6083522 | Chu et al. | Jul 2000 | A |
| 6090116 | D'Aversa et al. | Jul 2000 | A |
| 6113623 | Sgro | Sep 2000 | A |
| 6120539 | Eldridge et al. | Sep 2000 | A |
| 6132765 | DiCosmo et al. | Oct 2000 | A |
| 6143037 | Goldstein et al. | Nov 2000 | A |
| 6153292 | Bell et al. | Nov 2000 | A |
| 6162962 | Hinsch et al. | Dec 2000 | A |
| 6165488 | Tardy et al. | Dec 2000 | A |
| 6171318 | Kugel et al. | Jan 2001 | B1 |
| 6174320 | Kugel et al. | Jan 2001 | B1 |
| 6176863 | Kugel et al. | Jan 2001 | B1 |
| 6179872 | Bell et al. | Jan 2001 | B1 |
| 6180848 | Flament et al. | Jan 2001 | B1 |
| 6197325 | MacPhee et al. | Mar 2001 | B1 |
| 6197934 | DeVore et al. | Mar 2001 | B1 |
| 6197935 | Doillon et al. | Mar 2001 | B1 |
| 6210439 | Firmin et al. | Apr 2001 | B1 |
| 6214020 | Mulhauser et al. | Apr 2001 | B1 |
| 6221109 | Geistlich et al. | Apr 2001 | B1 |
| 6224616 | Kugel | May 2001 | B1 |
| 6241768 | Agarwal et al. | Jun 2001 | B1 |
| 6258124 | Darois et al. | Jul 2001 | B1 |
| 6262332 | Ketharanathan | Jul 2001 | B1 |
| 6264702 | Ory et al. | Jul 2001 | B1 |
| 6267772 | Mulhauser et al. | Jul 2001 | B1 |
| 6270530 | Eldridge et al. | Aug 2001 | B1 |
| 6277397 | Shimizu | Aug 2001 | B1 |
| 6280453 | Kugel et al. | Aug 2001 | B1 |
| 6287316 | Agarwal et al. | Sep 2001 | B1 |
| 6290708 | Kugel et al. | Sep 2001 | B1 |
| 6306079 | Trabucco | Oct 2001 | B1 |
| 6306424 | Vyakamam et al. | Oct 2001 | B1 |
| 6312474 | Francis et al. | Nov 2001 | B1 |
| 6319264 | Tormala et al. | Nov 2001 | B1 |
| 6328686 | Kovac | Dec 2001 | B1 |
| 6334872 | Termin et al. | Jan 2002 | B1 |
| 6383201 | Dong | May 2002 | B1 |
| 6391060 | Ory et al. | May 2002 | B1 |
| 6391333 | Li et al. | May 2002 | B1 |
| 6391939 | Tayot et al. | May 2002 | B2 |
| 6408656 | Ory et al. | Jun 2002 | B1 |
| 6410044 | Chudzik et al. | Jun 2002 | B1 |
| 6413742 | Olsen et al. | Jul 2002 | B1 |
| 6425924 | Rousseau | Jul 2002 | B1 |
| 6428978 | Olsen et al. | Aug 2002 | B1 |
| 6436030 | Rehil | Aug 2002 | B2 |
| 6440167 | Shimizu | Aug 2002 | B2 |
| 6443964 | Ory et al. | Sep 2002 | B1 |
| 6447551 | Goldmann | Sep 2002 | B1 |
| 6447802 | Sessions et al. | Sep 2002 | B2 |
| 6448378 | DeVore et al. | Sep 2002 | B2 |
| 6451032 | Ory et al. | Sep 2002 | B1 |
| 6451301 | Sessions et al. | Sep 2002 | B1 |
| 6454787 | Maddalo et al. | Sep 2002 | B1 |
| 6477865 | Matsumoto | Nov 2002 | B1 |
| 6479072 | Morgan et al. | Nov 2002 | B1 |
| 6485503 | Jacobs et al. | Nov 2002 | B2 |
| 6500464 | Ceres et al. | Dec 2002 | B2 |
| 6500777 | Wiseman et al. | Dec 2002 | B1 |
| 6509031 | Miller et al. | Jan 2003 | B1 |
| 6511958 | Atkinson et al. | Jan 2003 | B1 |
| 6514286 | Leatherbury et al. | Feb 2003 | B1 |
| 6514514 | Atkinson et al. | Feb 2003 | B1 |
| 6540773 | Dong | Apr 2003 | B2 |
| 6541023 | Andre et al. | Apr 2003 | B1 |
| 6548077 | Gunasekaran | Apr 2003 | B1 |
| 6554855 | Dong | Apr 2003 | B1 |
| 6559119 | Burgess et al. | May 2003 | B1 |
| 6566345 | Miller et al. | May 2003 | B2 |
| 6575988 | Rousseau | Jun 2003 | B2 |
| 6576019 | Atala | Jun 2003 | B1 |
| 6596002 | Therin et al. | Jul 2003 | B2 |
| 6596304 | Bayon et al. | Jul 2003 | B1 |
| 6599323 | Melican et al. | Jul 2003 | B2 |
| 6599524 | Li et al. | Jul 2003 | B2 |
| 6599690 | Abraham et al. | Jul 2003 | B1 |
| 6610006 | Amid et al. | Aug 2003 | B1 |
| 6613348 | Jain | Sep 2003 | B1 |
| 6616685 | Rousseau | Sep 2003 | B2 |
| 6623963 | Muller et al. | Sep 2003 | B1 |
| 6630414 | Matsumoto | Oct 2003 | B1 |
| 6637437 | Hungerford et al. | Oct 2003 | B1 |
| 6638284 | Rousseau et al. | Oct 2003 | B1 |
| 6645226 | Jacobs et al. | Nov 2003 | B1 |
| 6652594 | Francis et al. | Nov 2003 | B2 |
| 6652595 | Nicolo | Nov 2003 | B1 |
| 6653450 | Berg et al. | Nov 2003 | B1 |
| 6656206 | Corcoran et al. | Dec 2003 | B2 |
| 6660280 | Allard et al. | Dec 2003 | B1 |
| 6669735 | Pelissier | Dec 2003 | B1 |
| 6670018 | Fujita et al. | Dec 2003 | B2 |
| 6682760 | Noff et al. | Jan 2004 | B2 |
| 6685714 | Rousseau | Feb 2004 | B2 |
| 6706684 | Bayon et al. | Mar 2004 | B1 |
| 6706690 | Reich et al. | Mar 2004 | B2 |
| 6712859 | Rousseau et al. | Mar 2004 | B2 |
| 6719795 | Cornwall et al. | Apr 2004 | B1 |
| 6723335 | Moehlenbruck et al. | Apr 2004 | B1 |
| 6726660 | Hessel et al. | Apr 2004 | B2 |
| 6730299 | Tayot et al. | May 2004 | B1 |
| 6736823 | Darois et al. | May 2004 | B2 |
| 6736854 | Vadurro et al. | May 2004 | B2 |
| 6737371 | Planck et al. | May 2004 | B1 |
| 6743435 | DeVore et al. | Jun 2004 | B2 |
| 6746458 | Cloud | Jun 2004 | B1 |
| 6752834 | Geistlich et al. | Jun 2004 | B2 |
| 6755868 | Rousseau | Jun 2004 | B2 |
| 6773723 | Spiro et al. | Aug 2004 | B1 |
| 6783554 | Amara et al. | Aug 2004 | B2 |
| 6790213 | Cherok et al. | Sep 2004 | B2 |
| 6790454 | Abdul Malak et al. | Sep 2004 | B1 |
| 6800082 | Rousseau | Oct 2004 | B2 |
| 6833408 | Sehl et al. | Dec 2004 | B2 |
| 6835336 | Watt | Dec 2004 | B2 |
| 6852330 | Bowman et al. | Feb 2005 | B2 |
| 6869938 | Schwartz et al. | Mar 2005 | B1 |
| 6872227 | Sump et al. | Mar 2005 | B2 |
| 6893653 | Abraham et al. | May 2005 | B2 |
| 6896904 | Spiro et al. | May 2005 | B2 |
| 6926723 | Mulhauser et al. | Aug 2005 | B1 |
| 6936276 | Spiro et al. | Aug 2005 | B2 |
| 6939562 | Spiro et al. | Sep 2005 | B2 |
| 6949625 | Tayot | Sep 2005 | B2 |
| 6966918 | Schuldt-Hempe et al. | Nov 2005 | B1 |
| 6971252 | Therin et al. | Dec 2005 | B2 |
| 6974679 | Andre et al. | Dec 2005 | B2 |
| 6974862 | Ringeisen et al. | Dec 2005 | B2 |
| 6977231 | Matsuda | Dec 2005 | B1 |
| 6984392 | Bechert et al. | Jan 2006 | B2 |
| 6988386 | Okawa et al. | Jan 2006 | B1 |
| 7011688 | Gryska et al. | Mar 2006 | B2 |
| 7021086 | Ory et al. | Apr 2006 | B2 |
| 7022358 | Eckmayer et al. | Apr 2006 | B2 |
| 7025063 | Snitkin et al. | Apr 2006 | B2 |
| 7041868 | Greene et al. | May 2006 | B2 |
| 7060103 | Carr, Jr. et al. | Jun 2006 | B2 |
| RE39172 | Bayon et al. | Jul 2006 | E |
| 7070558 | Gellman et al. | Jul 2006 | B2 |
| 7087065 | Ulmsten et al. | Aug 2006 | B2 |
| 7094261 | Zotti et al. | Aug 2006 | B2 |
| 7098315 | Schaufler | Aug 2006 | B2 |
| 7101381 | Ford et al. | Sep 2006 | B2 |
| 7115220 | Dubson et al. | Oct 2006 | B2 |
| 7156804 | Nicolo | Jan 2007 | B2 |
| 7156858 | Schuldt-Hempe et al. | Jan 2007 | B2 |
| 7175852 | Simmoteit et al. | Feb 2007 | B2 |
| 7192604 | Brown et al. | Mar 2007 | B2 |
| 7207962 | Anand et al. | Apr 2007 | B2 |
| 7214765 | Ringeisen et al. | May 2007 | B2 |
| 7226611 | Yura et al. | Jun 2007 | B2 |
| 7229453 | Anderson et al. | Jun 2007 | B2 |
| 7252837 | Guo et al. | Aug 2007 | B2 |
| 7279177 | Looney et al. | Oct 2007 | B2 |
| 7331199 | Ory et al. | Feb 2008 | B2 |
| 7393319 | Merade et al. | Jul 2008 | B2 |
| 7556598 | Rao | Jul 2009 | B2 |
| 7594921 | Browning | Sep 2009 | B2 |
| 7614258 | Cherok et al. | Nov 2009 | B2 |
| 7615065 | Priewe et al. | Nov 2009 | B2 |
| 7662169 | Wittmann | Feb 2010 | B2 |
| 7670380 | Cauthen, III | Mar 2010 | B2 |
| 7682381 | Rakos et al. | Mar 2010 | B2 |
| 7709017 | Tayot | May 2010 | B2 |
| 7718556 | Matsuda et al. | May 2010 | B2 |
| 7732354 | Fricke et al. | Jun 2010 | B2 |
| 7785334 | Ford et al. | Aug 2010 | B2 |
| 7789888 | Bartee et al. | Sep 2010 | B2 |
| 7799767 | Lamberti et al. | Sep 2010 | B2 |
| 7806905 | Ford et al. | Oct 2010 | B2 |
| 7824420 | Eldridge et al. | Nov 2010 | B2 |
| 7828854 | Rousseau et al. | Nov 2010 | B2 |
| 7900484 | Cherok et al. | Mar 2011 | B2 |
| 7931695 | Ringeisen | Apr 2011 | B2 |
| 8052759 | Dupic et al. | Nov 2011 | B2 |
| 8079023 | Chen | Dec 2011 | B2 |
| 8100924 | Browning | Jan 2012 | B2 |
| 8123817 | Intoccia et al. | Feb 2012 | B2 |
| 8142515 | Therin et al. | Mar 2012 | B2 |
| 8157821 | Browning | Apr 2012 | B2 |
| 8157822 | Browning | Apr 2012 | B2 |
| 8182545 | Cherok et al. | May 2012 | B2 |
| 8197837 | Jamiolkowski et al. | Jun 2012 | B2 |
| 8206632 | Rousseau et al. | Jun 2012 | B2 |
| 8215310 | Browning | Jul 2012 | B2 |
| 8317872 | Adams | Nov 2012 | B2 |
| 8323675 | Greenawalt | Dec 2012 | B2 |
| 8343232 | Adzich et al. | Jan 2013 | B2 |
| 8366787 | Brown et al. | Feb 2013 | B2 |
| 8435307 | Paul | May 2013 | B2 |
| 8470355 | Skalla et al. | Jun 2013 | B2 |
| 8562633 | Cully et al. | Oct 2013 | B2 |
| 8574627 | Martakos et al. | Nov 2013 | B2 |
| 8709094 | Stad et al. | Apr 2014 | B2 |
| 8734471 | Deitch | May 2014 | B2 |
| 8753360 | Gleiman et al. | Jun 2014 | B2 |
| 8758800 | Stopek et al. | Jun 2014 | B2 |
| 8784294 | Goddard | Jul 2014 | B2 |
| 8814887 | Walther et al. | Aug 2014 | B2 |
| 8828092 | Toso et al. | Sep 2014 | B2 |
| 8834864 | Odar et al. | Sep 2014 | B2 |
| 8846060 | Archibald et al. | Sep 2014 | B2 |
| 8865215 | Ladet et al. | Oct 2014 | B2 |
| 8877233 | Obermiller et al. | Nov 2014 | B2 |
| 8911504 | Mathisen et al. | Dec 2014 | B2 |
| 8920370 | Sholev et al. | Dec 2014 | B2 |
| 8956373 | Ford et al. | Feb 2015 | B2 |
| 8962006 | Bayon et al. | Feb 2015 | B2 |
| 8968762 | Ladet et al. | Mar 2015 | B2 |
| 8979935 | Lozier et al. | Mar 2015 | B2 |
| 9034357 | Stopek | May 2015 | B2 |
| 9113993 | Lee | Aug 2015 | B2 |
| 9211175 | Stopek et al. | Dec 2015 | B2 |
| 9216075 | Bailly et al. | Dec 2015 | B2 |
| 20020087174 | Cabello | Jul 2002 | A1 |
| 20020095218 | Carr et al. | Jul 2002 | A1 |
| 20030086975 | Ringeisen | May 2003 | A1 |
| 20030106346 | Matsumoto | Jun 2003 | A1 |
| 20030114937 | Leatherbury et al. | Jun 2003 | A1 |
| 20030133967 | Ruszczak et al. | Jul 2003 | A1 |
| 20030212462 | Gryska et al. | Nov 2003 | A1 |
| 20030225355 | Butler | Dec 2003 | A1 |
| 20040019360 | Farnsworth | Jan 2004 | A1 |
| 20040034373 | Schuldt-Hempe et al. | Feb 2004 | A1 |
| 20040054376 | Ory et al. | Mar 2004 | A1 |
| 20040059356 | Gingras | Mar 2004 | A1 |
| 20040101546 | Gorman et al. | May 2004 | A1 |
| 20040215219 | Eldridge | Oct 2004 | A1 |
| 20050002893 | Goldmann | Jan 2005 | A1 |
| 20050021058 | Negro | Jan 2005 | A1 |
| 20050085924 | Darois et al. | Apr 2005 | A1 |
| 20050113849 | Popadiuk et al. | May 2005 | A1 |
| 20050137512 | Campbell et al. | Jun 2005 | A1 |
| 20050142161 | Freeman et al. | Jun 2005 | A1 |
| 20050148963 | Brennan | Jul 2005 | A1 |
| 20050175659 | Macomber et al. | Aug 2005 | A1 |
| 20050232979 | Shoshan | Oct 2005 | A1 |
| 20050267521 | Forsberg | Dec 2005 | A1 |
| 20050288691 | Leiboff | Dec 2005 | A1 |
| 20060015143 | Alvarado | Jan 2006 | A1 |
| 20060116696 | Odermatt et al. | Jun 2006 | A1 |
| 20060135921 | Wiercinski et al. | Jun 2006 | A1 |
| 20060147501 | Hillas et al. | Jul 2006 | A1 |
| 20060216320 | Kitazono et al. | Sep 2006 | A1 |
| 20060252981 | Matsuda et al. | Nov 2006 | A1 |
| 20060253203 | Alvarado | Nov 2006 | A1 |
| 20060282103 | Fricke et al. | Dec 2006 | A1 |
| 20070088391 | McAlexander et al. | Apr 2007 | A1 |
| 20070129736 | Solecki | Jun 2007 | A1 |
| 20070198040 | Buevich et al. | Aug 2007 | A1 |
| 20070299538 | Roeber | Dec 2007 | A1 |
| 20080091276 | Deusch et al. | Apr 2008 | A1 |
| 20080109017 | Herweck et al. | May 2008 | A1 |
| 20080113001 | Herweck et al. | May 2008 | A1 |
| 20080172071 | Barker | Jul 2008 | A1 |
| 20080255593 | St-Germain | Oct 2008 | A1 |
| 20090035341 | Wagener et al. | Feb 2009 | A1 |
| 20090036996 | Roeber | Feb 2009 | A1 |
| 20090068250 | Gravagna et al. | Mar 2009 | A1 |
| 20090105526 | Piroli Torelli et al. | Apr 2009 | A1 |
| 20090163936 | Yang et al. | Jun 2009 | A1 |
| 20090187197 | Roeber et al. | Jul 2009 | A1 |
| 20090192530 | Adzich et al. | Jul 2009 | A1 |
| 20090204129 | Fronio | Aug 2009 | A1 |
| 20090216338 | Gingras et al. | Aug 2009 | A1 |
| 20090270999 | Brown | Oct 2009 | A1 |
| 20090281558 | Li | Nov 2009 | A1 |
| 20090318752 | Evans et al. | Dec 2009 | A1 |
| 20100104608 | Abuzaina et al. | Apr 2010 | A1 |
| 20100318108 | Datta et al. | Dec 2010 | A1 |
| 20110015760 | Kullas | Jan 2011 | A1 |
| 20110144667 | Horton et al. | Jun 2011 | A1 |
| 20110190795 | Hotter et al. | Aug 2011 | A1 |
| 20110238094 | Thomas et al. | Sep 2011 | A1 |
| 20110251699 | Ladet | Oct 2011 | A1 |
| 20110257666 | Ladet et al. | Oct 2011 | A1 |
| 20120016388 | Houard et al. | Jan 2012 | A1 |
| 20120029537 | Mortarino | Feb 2012 | A1 |
| 20120065727 | Reneker et al. | Mar 2012 | A1 |
| 20120082712 | Stopek et al. | Apr 2012 | A1 |
| 20120116425 | Intoccia et al. | May 2012 | A1 |
| 20120150204 | Mortarino et al. | Jun 2012 | A1 |
| 20120165937 | Montanari et al. | Jun 2012 | A1 |
| 20120179175 | Hammell | Jul 2012 | A1 |
| 20120179176 | Wilson et al. | Jul 2012 | A1 |
| 20120197415 | Montanari et al. | Aug 2012 | A1 |
| 20130317527 | Jacinto | Nov 2013 | A1 |
| 20140044861 | Boey et al. | Feb 2014 | A1 |
| 20140364684 | Lecuivre | Dec 2014 | A1 |
| 20150094743 | Russo | Apr 2015 | A1 |
| Number | Date | Country |
|---|---|---|
| 1317836 | May 1993 | CA |
| 201879864 | Jun 2011 | CN |
| 19544162 | Apr 1997 | DE |
| 19718903 | Dec 1997 | DE |
| 19751733 | Dec 1998 | DE |
| 19832634 | Jan 2000 | DE |
| 10019604 | Oct 2001 | DE |
| 10120942 | Oct 2001 | DE |
| 10043396 | Jun 2002 | DE |
| 0194192 | Sep 1986 | EP |
| 0248544 | Dec 1987 | EP |
| 0263360 | Apr 1988 | EP |
| 0276890 | Aug 1988 | EP |
| 0372969 | Jun 1990 | EP |
| 0531742 | Mar 1993 | EP |
| 544485 | Jun 1993 | EP |
| 0552576 | Jul 1993 | EP |
| 0611561 | Aug 1994 | EP |
| 614650 | Sep 1994 | EP |
| 0621014 | Oct 1994 | EP |
| 0625891 | Nov 1994 | EP |
| 0637452 | Feb 1995 | EP |
| 0664132 | Jul 1995 | EP |
| 0705878 | Apr 1996 | EP |
| 0719527 | Jul 1996 | EP |
| 0774240 | May 1997 | EP |
| 0797962 | Oct 1997 | EP |
| 0800791 | Oct 1997 | EP |
| 827724 | Mar 1998 | EP |
| 0836838 | Apr 1998 | EP |
| 0847727 | Jun 1998 | EP |
| 0876808 | Nov 1998 | EP |
| 0895762 | Feb 1999 | EP |
| 898944 | Mar 1999 | EP |
| 1017415 | Jul 2000 | EP |
| 1036545 | Sep 2000 | EP |
| 1052319 | Nov 2000 | EP |
| 1055757 | Nov 2000 | EP |
| 1090590 | Apr 2001 | EP |
| 1 216 717 | Jun 2002 | EP |
| 1 216 718 | Jun 2002 | EP |
| 0693523 | Nov 2002 | EP |
| 1273312 | Jan 2003 | EP |
| 1315468 | Jun 2003 | EP |
| 1382728 | Jan 2004 | EP |
| 1484070 | Dec 2004 | EP |
| 1561480 | Aug 2005 | EP |
| 1645232 | Apr 2006 | EP |
| 1674048 | Jun 2006 | EP |
| 1691606 | Aug 2006 | EP |
| 1782848 | May 2007 | EP |
| 2229918 | Sep 2010 | EP |
| 2 853 231 | Apr 2015 | EP |
| 2244853 | Apr 1975 | FR |
| 2257262 | Aug 1975 | FR |
| 2 308 349 | Nov 1976 | FR |
| 2453231 | Oct 1980 | FR |
| 2612392 | Sep 1988 | FR |
| 2715309 | Jul 1995 | FR |
| 2715405 | Jul 1995 | FR |
| 2 724 563 | Mar 1996 | FR |
| 2730406 | Aug 1996 | FR |
| 2744906 | Aug 1997 | FR |
| 2766698 | Feb 1999 | FR |
| 2771622 | Jun 1999 | FR |
| 2773057 | Jul 1999 | FR |
| 2774277 | Aug 1999 | FR |
| 2779937 | Dec 1999 | FR |
| 2859624 | Mar 2005 | FR |
| 2863277 | Jun 2005 | FR |
| 2876020 | Apr 2006 | FR |
| 2884706 | Oct 2006 | FR |
| 2929834 | Oct 2009 | FR |
| 2953709 | Jun 2011 | FR |
| 1174814 | Dec 1969 | GB |
| 2 051 153 | Jan 1981 | GB |
| 2306110 | Apr 1997 | GB |
| H0332677 | Feb 1991 | JP |
| H05237128 | Sep 1993 | JP |
| H09137380 | May 1997 | JP |
| H11146888 | Jun 1999 | JP |
| 2008538300 | Oct 2008 | JP |
| 2011078767 | Apr 2011 | JP |
| 8902445 | Mar 1989 | WO |
| 8908467 | Sep 1989 | WO |
| 9012551 | Nov 1990 | WO |
| 9206639 | Apr 1992 | WO |
| 9220349 | Nov 1992 | WO |
| 9311805 | Jun 1993 | WO |
| 9310731 | Jun 1993 | WO |
| 9318174 | Sep 1993 | WO |
| 9417747 | Aug 1994 | WO |
| 9507666 | Mar 1995 | WO |
| 9518638 | Jul 1995 | WO |
| 9532687 | Dec 1995 | WO |
| 9603091 | Feb 1996 | WO |
| 9608277 | Mar 1996 | WO |
| 9609795 | Apr 1996 | WO |
| 9614805 | May 1996 | WO |
| 9641588 | Dec 1996 | WO |
| 9735533 | Oct 1997 | WO |
| 9835632 | Aug 1998 | WO |
| 9849967 | Nov 1998 | WO |
| 9905990 | Feb 1999 | WO |
| 9906079 | Feb 1999 | WO |
| 9906080 | Feb 1999 | WO |
| 9951163 | Oct 1999 | WO |
| 0016821 | Mar 2000 | WO |
| 0067663 | Nov 2000 | WO |
| 0115625 | Mar 2001 | WO |
| 0180773 | Nov 2001 | WO |
| 0181667 | Nov 2001 | WO |
| 02007648 | Jan 2002 | WO |
| 0217853 | Mar 2002 | WO |
| 00078568 | Oct 2002 | WO |
| 03002168 | Jan 2003 | WO |
| 2004004600 | Jan 2004 | WO |
| 2004071349 | Aug 2004 | WO |
| 2004078120 | Sep 2004 | WO |
| 2004103212 | Dec 2004 | WO |
| 200511280 | Feb 2005 | WO |
| 2005013863 | Feb 2005 | WO |
| 2005018698 | Mar 2005 | WO |
| 2005048708 | Jun 2005 | WO |
| 2005105172 | Nov 2005 | WO |
| 2006018552 | Feb 2006 | WO |
| 2006023444 | Mar 2006 | WO |
| 2006032812 | Mar 2006 | WO |
| 2007048099 | Apr 2007 | WO |
| 2009031035 | Mar 2009 | WO |
| 2009071998 | Jun 2009 | WO |
| 2010043978 | Apr 2010 | WO |
| 2011007062 | Jan 2011 | WO |
| 2011026987 | Mar 2011 | WO |
| 2011038740 | Apr 2011 | WO |
| Entry |
|---|
| Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36. |
| Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7). |
| Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004. |
| Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165. |
| Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4). |
| Haneji, K. et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009. |
| Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg., Sep. 2002, pp. 1472-1480, 26. |
| Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J. Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63. |
| Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5. |
| Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299. |
| Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4). |
| Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220,18(2). |
| Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4). |
| Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215,126(3). |
| Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007. |
| Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003. |
| Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1). |
| O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2). |
| Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10. |
| Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5). |
| Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6). |
| Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2. |
| Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle,” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3). |
| Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19. |
| Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34. |
| Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136. |
| Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25. |
| Dr. S. Raz, “The Karl Mayer Guide to Tehnical Textiles,” Jan. 2000, pp. 1-36, Obertshausen, Germany. |
| Chen, G. et al., “A Hybrid Network of Synthetic Polymer Mesh and Collagen Sponge,” The Royal Society of Chemistry 2000, Chem. Commun., Jul. 2000, pp. 1505-1506. |
| European Search Report for EP 16305063.6 date of completion is Jul. 12, 2016 (4 pages). |
| Number | Date | Country | |
|---|---|---|---|
| 20170209251 A1 | Jul 2017 | US |
